These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 17374617

  • 1. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope.
    Sadoulet MO, Franceschi C, Aubert M, Silvy F, Bernard JP, Lombardo D, Mas E.
    Glycobiology; 2007 Jun; 17(6):620-30. PubMed ID: 17374617
    [Abstract] [Full Text] [Related]

  • 2. The formation of the oncofetal J28 glycotope involves core-2 beta6-N-acetylglucosaminyltransferase and alpha3/4-fucosyltransferase activities.
    Panicot L, Mas E, Pasqualini E, Zerfaoui M, Lombardo D, Sadoulet MO, El Battari A.
    Glycobiology; 1999 Sep; 9(9):935-46. PubMed ID: 10460835
    [Abstract] [Full Text] [Related]

  • 3. Relationship between alphaGal epitope expression and decrease of tumorigenicity in pancreatic adenocarcinoma model.
    Aubert M, Crotte C, Benkoel L, Panicot-Dubois L, Bernard JP, Lombardo D, Sadoulet MO, Mas E.
    Mol Carcinog; 2005 Apr; 42(4):202-12. PubMed ID: 15761838
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decrease of human pancreatic cancer cell tumorigenicity by alpha1,3galactosyltransferase gene transfer.
    Aubert M, Crotte C, Bernard JP, Lombardo D, Sadoulet MO, Mas E.
    Int J Cancer; 2003 Dec 20; 107(6):910-8. PubMed ID: 14601050
    [Abstract] [Full Text] [Related]

  • 7. A novel tumor-associated pancreatic glycoprotein is internalized by human dendritic cells and induces their maturation.
    Franceschi C, Collignon A, Isnardon D, Benkoel L, Vérine A, Silvy F, Bernard JP, Lombardo D, Beraud E, Olive D, Mas E.
    J Immunol; 2011 Apr 01; 186(7):4067-77. PubMed ID: 21346236
    [Abstract] [Full Text] [Related]

  • 8. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O, Plumas J, Lui G, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Galili U.
    Haematologica; 2005 May 01; 90(5):625-34. PubMed ID: 15921377
    [Abstract] [Full Text] [Related]

  • 9. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
    Deguchi T, Tanemura M, Miyoshi E, Nagano H, Machida T, Ohmura Y, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Ito T, Mori M, Doki Y, Sawa Y.
    Cancer Res; 2010 Jul 01; 70(13):5259-69. PubMed ID: 20530670
    [Abstract] [Full Text] [Related]

  • 10. A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination.
    Collignon A, Perles-Barbacaru AT, Robert S, Silvy F, Martinez E, Crenon I, Germain S, Garcia S, Viola A, Lombardo D, Mas E, Béraud E.
    Oncotarget; 2015 Sep 15; 6(27):23462-79. PubMed ID: 26405163
    [Abstract] [Full Text] [Related]

  • 11. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
    LaTemple DC, Henion TR, Anaraki F, Galili U.
    Cancer Res; 1996 Jul 01; 56(13):3069-74. PubMed ID: 8674064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The αGal HyperAcute(®) Technology: enhancing immunogenicity of antiviral vaccines by exploiting the natural αGal-mediated zoonotic blockade.
    Mandell RB, Flick R, Staplin WR, Kaniewski LD, Carzoli AK, Manuszak RP, Wang J, Rossi GR, Vahanian NN, Link CJ.
    Zoonoses Public Health; 2009 Aug 01; 56(6-7):391-406. PubMed ID: 19486321
    [Abstract] [Full Text] [Related]

  • 18. Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.
    Posekany KJ, Pittman HK, Swanson MS, Haisch CE, Verbanac KM.
    Anticancer Res; 2004 Aug 01; 24(2B):605-12. PubMed ID: 15161001
    [Abstract] [Full Text] [Related]

  • 19. Reduction of alpha-galactosyl xenoantigen by expression of endo-beta-galactosidase C in pig endothelial cells.
    Ogawa H, Kobayashi T, Yokoyama I, Nagatani N, Mizuno M, Yoshida J, Kadomatsu K, Muramatsu H, Nakao A, Muramatsu T.
    Xenotransplantation; 2002 Jul 01; 9(4):290-6. PubMed ID: 12060465
    [Abstract] [Full Text] [Related]

  • 20. A novel method to display [gal alpha1, 3 gal] antigens on human leukemic cells for preparation of anti-leukemia vaccines.
    Posekany KJ, Wiley JE, Gagnon GA.
    Anticancer Res; 2009 Jun 01; 29(6):2387-92. PubMed ID: 19528506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.